Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression

Recruiting

Phase 2

Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of DepressionKetamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression

Sponsor:

Icahn School of Medicine at Mount Sinai

Code:

NCT06559826

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ketamine

Psychotherapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-25. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2025-01-24.